VIGIL NEUROSCIENCE, INC.
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About VIGL
Vigil Neuroscience, Inc. is a clinical-stage biotechnology company, which is focused on developing treatments for both rare and common neurodegenerative diseases by restoring the vigilance of microglia, the sentinel immune cells of the brain. It is utilizing the tools of modern neuroscience drug development across multiple therapeutic modalities in its efforts to develop precision-based therapies to improve the lives of patients and their families. Its lead clinical candidate, iluzanebart, is a fully human monoclonal antibody agonist targeting the triggering receptor expressed on myeloid cells 2 (TREM2) in people with adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP), a rare and fatal neurodegenerative disease. The Company is also developing VG-3927, a novel small molecule TREM2 agonist, to treat common neurodegenerative diseases associated with microglial dysfunction, with an initial focus on Alzheimer’s disease (AD).
Find out what a historical investment in VIGIL NEUROSCIENCE, INC. would be worth today using our VIGL stock calculator.
$118.08M
-
0.00%
61
$2.65
$2.29
$0.00
$6.06
$1.31
Ready to start your investing journey with Stake?
Open an accountVIGL FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in VIGL
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in VIGL
on Stake
Buy VIGL from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of VIGL from only US$10 with fractional shares
